NHFA CONSENSUS STATEMENT ON DEPRESSION IN PATIENTS WITH CORONARY HEART DISEASE

Size: px
Start display at page:

Download "NHFA CONSENSUS STATEMENT ON DEPRESSION IN PATIENTS WITH CORONARY HEART DISEASE"

Transcription

1 NHFA CONSENSUS STATEMENT ON DEPRESSION IN PATIENTS WITH CORONARY HEART DISEASE Associate Professor David Colquhoun 19th October 2013 University of Queensland, Wesley & Greenslopes Hospitals, Brisbane, Australia Slides prepared by David Colquhoun & Jenni Shields

2 What is Depression? Depression is more than just a low mood it s a serious illness. While we all feel sad, moody or low from time to time, some people experience these feelings intensely, for a long time and often without reason. People with depression find it hard to function every day and may be reluctant to participate in activities they once enjoyed. Depression is one of the most common of all mental health problems. One in five people experience depression at some stage of their lives. Ref: BeyondBlue: the national depression and anxiety initiative.

3 Thorpe - Depression

4 Depression and Cardiovascular Mortality Post-MI: 6 and 18 Month Outcome Adjusted RR: at 6 mos = 3.10; at 18 mos: 3.64 Non-depressed Depressed 20% % % 5 3% % of coronary deaths months 18 months Frasure-Smith N et al. JAMA 1993;270: Frasure-Smith N et al. Circ 1995;91:

5 PREVALENCE RATES OF MAJOR DEPRESSION IN PATIENTS WITH CARDIOVASCULAR ILLNESS 15-20% Unstable Angina % CHF % MI % CAD-1 0% 10% 20% 30% 40% prevalence rate, % 1-Carney. 1995; Hance, 1996; Gonzalez, 1996; Sullivan, 1999; Connerney, 2001; 2-Schleifer, 1989; Ladwig, 1991; Frasure-Smith, 1995; Jiang, 2001; 3-Jiang, 2001; Koenig, 1998; Frasure-Smith, 1993; 4Lesperance, 2000

6 Lipid Cohort Study This image cannot currently be display ed. Prevalence Of Depression Sub-study 715 of 7883 patients 25 Australian and 7 New Zealand Centres Beck Depression Inventory (BDI-II) >10 Males 27% Females 38% Baseline characteristics similar in depressed and non-depressed No association of depression with Pravastatin treatment in LIPID trial Weyers J, Colquhoun D, Stewart R. Atherosclerosis 2000;151:1-354

7 Depression and Symptoms major factor in quality of life greater symptoms if angina and atypical chest pains Channer KR. J R Soc Med 1998;81: Channer KS. Stress Med 1987;3: Sirois BS. J Behavioral Med 2003;26(6):

8 Risk ratios of classic risk factors and depression Risk ratios of traditional risk factors in the Framingham study compared to risk ratios by meta-analysis by Rugulies. REF: Blumenthal J. Cleveland Clinic Journal of Medicine (2):S48-S53

9 Lett HS, Blumenthal JA, Babyak MA et al. Depression as a Risk Factor for Coronary Artery Disease: Evidence, Mechanisms and Treatment. Psychosomatic Med 2004;66:

10 Improvement of Depression leads to subsequent improved drug adherence in CHD patients 2006 Observational Study which noted improvement (BDI) in depression associated with subsequent improved aspirin adherence (electronic bottle) SADHART noted after remission of depression improved adherence (BDI) Collaborative Care depression treatment program noted improvement in depression (PHQ-9) was associated with subsequent improved drug adherence (P <0.001) Change in anxiety had no relationship to adherence.3 1) Rieckmann N, et al. J Am Coll Cardiol 2006;48: ) Glassman AH, et al. Arch Gen Psychiatry 2009;66(9): ) Bauer L, et al. Am J Cardiol 2012;109:

11 Need for a Screening Tool? For Depression in CHD patients It is a prevalent condition in patients with CHD/risk factors for CHD! 1) Misdiagnosis / non-diagnosis in hospital by medical practitioners and nurses. 2) Misdiagnosis in general practice

12 Recognition of Depression Myocardial Infarction Patients 60 patients clinical impression Vs BDI Johns Hopkins Bayview Medical Centre 30% BDI 10 (depressed) within 5 days of AMI 24 of 32 patient assessments not depressed when BDI 10 (i.e. 75% false negative) 13 of 17 patients assessed not depressed when BDI < 10 (cardiologists) (i.e. 24% false positive) Ziegelstein RC, Bush DE. Psychosomatic Med 2005;67:

13

14 Published in 2000 Page 356

15 National Heart Foundation of Australia Recommended Screening Tool Patient Health Questionnaire (PHQ-2) YES/NO Version (1) During the past month, have you often been bothered by feeling down, depressed or hopeless? (2) During the past month, have you often been bothered by little interest or pleasure in doing things? * Yes to either question is sufficient for a provisional diagnosis of depression. Elderon L et al. Screening for Depression: Heart And Soul Study. Circ. Cardio Qual Outcomes 2011;4: McManus D. Screening for Depression: Heart And Soul Study Am J Cardiol 2005;96(8): Expert Group. NHFA Consensus Statement. MJA On Line 1st May 2013

16 PHQ2 (Yes/No Version) Prognosis in Heart and Soul Study n=1,024 CHD patients mean 6.27 year follow up. PHQ2 Yes/No Version Yes to either question predicted 55% greater CV events P= Elderon L, Smolderen K, Na B, Whooley MA. Circ Cardiovasc Qual Outcomes 2011;4:

17 Summary Patient Health Questionnaire Yes/No Version Recommended screening tool of the NHFA Ease to remember and use (takes less time than to do a reliable BP!) Ought to be part of usual history taking Widely recommended and used internationally Reasonable sensitivity and specificity compared to psychiatric interview or extensive questionnaires Validated in multiple population and ethnic groups including Indigenous Australians Available at no cost (no royalties)

18

19 NHFA consensus recommendations for treatment Exercise Psychosocial - cognitive behavioural therapy - interpersonal psychotherapy Complementary Therapies - up to 50% of depressed patients use these Drugs - mainly serotonin reuptake inhibitors (SSRIs) (Sertraline, Fluoxetine, Citalopram, Mirtazapine) have been tested. - avoid tricyclic antidepressants (TCA) as may increase mortality rates. NHFA Consensus Statement. MJA On Line May 2013

20

21 Definition of NHMRC Grades of Recommendations Definition of NHMRC Grades of recommendations Grade of Recommendation Description A Body of evidence can be trusted to guide practice B Body of evidence can be trusted to guide practice in most situations C Body of evidence provides some support for recommendation (s) but care should be taken in its application D Body of evidence is weak and recommendation must be applied with caution

22 NHMRC Levels of Evidence NHMRC Evidence Hierarchy: Designation of Levels of Evidence Level Intervention I A systematic review of level II studies II A randomised controlled trial II-1 A pseudorandomised controlled trial (i.e. alternate allocation or some other method) III-2 A comparative study with concurrent controls: Non-randomised, experimental trial Cohort Study Case-control study Interrupted time series with a control group III-3 A comparative study without concurrent controls: Historical control study Two or more single arm study Interrupted time series without a parallel control group IV Case series with either post-test or pre-test/post-test outcomes

23 NHFA recommendations for screening and treatment of depression in patients with CHD Recommendation Grade of Recommendation Level of Evidence 1. For patients with CHD, it is reasonable to screen for depression Grade A Level I 2. Treatment of depression in CHD patients is effective in decreasing depression Grade A Level I 3. Treatment of depression in CHD patients improves CHD outcomes Grade D Level II 4. Treatment of depression in CHD patients changes behavioural risk factors/adherence Grade B Level III-2 5. Exercise is an effective treatment of depression in patients with CHD Grade A Level I 6. Exercise improves CHD outcomes in patients with CHD Grade B Level II NHFA Consensus Expert Group. Med J Aust 2013; on line

24 Conclusion Depression is common in CHD pts Detection is easy Treatment is effective and safe Recognise and treat NOW - to relieve suffering - probably to improve adherence - possibly to improve CHD prognosis

25

Depression in Peripheral Artery Disease: An important Predictor of Outcome. Goals. Goals. Marlene Grenon, MD Assistant Professor of Surgery, UCSF

Depression in Peripheral Artery Disease: An important Predictor of Outcome. Goals. Goals. Marlene Grenon, MD Assistant Professor of Surgery, UCSF Depression in Peripheral Artery Disease: An important Predictor of Outcome There are no conflicts of interest Marlene Grenon, MD Assistant Professor of Surgery, UCSF UCSF VASCULAR SURGERY SYMPOSIUM SAN

More information

Depression and CV Disease A Depressing Story. Bertram Pitt, M.D. University of Michigan School of Medicine

Depression and CV Disease A Depressing Story. Bertram Pitt, M.D. University of Michigan School of Medicine A Depressing Story Bertram Pitt, M.D. University of Michigan School of Medicine Davos 2011 HF affects > 5 million people in the US 15-20% of patients with HF have depression Patients with HF + depression

More information

Supporting your patient s mental health. March 2019

Supporting your patient s mental health. March 2019 Supporting your patient s mental health March 2019 Emotions after a cardiac event Acute response Adjustment, new normal change in role/ dependence, new meds etc overwhelmed, anger, denial, grief, anxiety,

More information

A Practical Strategy to Screen Cardiac Patients for Depression

A Practical Strategy to Screen Cardiac Patients for Depression A Practical Strategy to Screen Cardiac Patients for Depression Bruce L. Rollman, M.D., M.P.H. Associate Professor of Medicine and Psychiatry Center for Research on Health Care Division of General Internal

More information

Comparison of Depression Interventions after Acute Coronary Syndrome

Comparison of Depression Interventions after Acute Coronary Syndrome Comparison of Depression Interventions after Acute Coronary Syndrome Funded by the National Heart Lung and Blood Institute RC2-HL HL-101663 Depressive Symptoms are Related to Acute Coronary Events Increased

More information

The Bypassing the Blues Trial: Telephone-Delivered Collaborative Care for Treating Post-CABG Depression

The Bypassing the Blues Trial: Telephone-Delivered Collaborative Care for Treating Post-CABG Depression The Bypassing the Blues Trial: Telephone-Delivered Collaborative Care for Treating Post-CABG Depression www.bypassingtheblues.pitt.edu Bruce L. Rollman, MD, MPH Professor of Medicine, Psychiatry, and Clinical

More information

Omega-3s and Heart Health An Australian Perspective

Omega-3s and Heart Health An Australian Perspective Omega-3s and Heart Health An Australian Perspective Associate Professor David Colquhoun 7 th November, 2013 University of Queensland, Greenslopes & Wesley Hospitals, Brisbane www.coreresearchgroup.com

More information

Stress Reactions and. Depression After. Cardiovascular Events

Stress Reactions and. Depression After. Cardiovascular Events Stress Reactions and Depression After Cardiovascular Events Kim G. Smolderen, PhD Tilburg University, the Netherlands Saint Luke s Mid America Heart Institute, Kansas City, MO ESC Munich 2012 Disclosures

More information

Cardiac Rehabilitation Should be Paid in Korea?

Cardiac Rehabilitation Should be Paid in Korea? Cardiac Rehabilitation Should be Paid in Korea? Cardiac prevention & Rehabilitation Center, Heart Institute, Asan Medical Center, Seoul, Korea Jong-Young Lee, MD. NO CONFLICT OF INTEREST TO DECLARE Before

More information

Copyright Medinews (Cardiology) Limited Reproduction Prohibited

Copyright Medinews (Cardiology) Limited Reproduction Prohibited Meeting the psychological needs of cardiac patients: an integrated stepped-care approach within a cardiac rehabilitation setting Alison Child, Jane Sanders, Paul Sigel, Myra S Hunter Authors Alison Child

More information

NIH Public Access Author Manuscript Am J Cardiol. Author manuscript; available in PMC 2009 November 12.

NIH Public Access Author Manuscript Am J Cardiol. Author manuscript; available in PMC 2009 November 12. NIH Public Access Author Manuscript Published in final edited form as: Am J Cardiol. 2005 October 15; 96(8): 1076 1081. doi:10.1016/j.amjcard.2005.06.037. Screening for Depression in Patients With Coronary

More information

Depression in Primary Care Mitchell D. Feldman, MD, MPhil Professor Of Medicine Director of Faculty Mentoring University of California, San Francisco

Depression in Primary Care Mitchell D. Feldman, MD, MPhil Professor Of Medicine Director of Faculty Mentoring University of California, San Francisco Epidemiology of Depression in Primary Care Depression in Primary Care Mitchell D. Feldman, MD, MPhil Professor Of Medicine Director of Faculty Mentoring University of California, San Francisco Stafford

More information

NIH Public Access Author Manuscript Cleve Clin J Med. Author manuscript; available in PMC 2010 August 9.

NIH Public Access Author Manuscript Cleve Clin J Med. Author manuscript; available in PMC 2010 August 9. NIH Public Access Author Manuscript Published in final edited form as: Cleve Clin J Med. 2010 July ; 77(Suppl 3): S20 S26. doi:10.3949/ccjm.77.s3.04. Depression and Cardiovascular Disease: Selected Findings,

More information

Screening for Depression in Patients With Coronary Heart Disease (Data from the Heart and Soul Study)

Screening for Depression in Patients With Coronary Heart Disease (Data from the Heart and Soul Study) Screening for Depression in Patients With Coronary Heart Disease (Data from the Heart and Soul Study) David McManus, MD a,c, Sharon S. Pipkin, MPH c, and Mary A. Whooley, MD a,b,c, * Major depression is

More information

NIH Public Access Author Manuscript JAMA Intern Med. Author manuscript; available in PMC 2014 June 24.

NIH Public Access Author Manuscript JAMA Intern Med. Author manuscript; available in PMC 2014 June 24. NIH Public Access Author Manuscript Published in final edited form as: JAMA Intern Med. 2013 June 24; 173(12): 1150 1151. doi:10.1001/jamainternmed.2013.910. SSRI Use, Depression and Long-Term Outcomes

More information

M ajor depression after myocardial infarction (MI) is a

M ajor depression after myocardial infarction (MI) is a 1656 CARDIOVASCULAR MEDICINE Rapid screening for major depression in postmyocardial infarction patients: an investigation using Beck Depression Inventory II items J C Huffman, F A Smith, M A Blais, M E

More information

NIH Public Access Author Manuscript Psychother Psychosom. Author manuscript; available in PMC 2013 June 01.

NIH Public Access Author Manuscript Psychother Psychosom. Author manuscript; available in PMC 2013 June 01. NIH Public Access Author Manuscript Published in final edited form as: Psychother Psychosom. 2012 ; 81(4): 245 247. doi:10.1159/000332439. The Effect of Enhanced Depression Care on Anxiety Symptoms in

More information

PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA

PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA CASE #1 PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA OBJECTIVES Epidemiology Presentation in older adults Assessment Treatment

More information

Psychosocial Influences on Coronary Heart Disease (CHD)

Psychosocial Influences on Coronary Heart Disease (CHD) Psychosocial Influences on Coronary Heart Disease (CHD) Dr Rachel O Hara Section of Public Health School of Health and Related Research r.ohara@sheffield.ac.uk Learning objectives To examine the role of

More information

Depression, isolation, social support and cardiovascular rehabilitation in older adults

Depression, isolation, social support and cardiovascular rehabilitation in older adults Depression, isolation, social support and cardiovascular rehabilitation in older adults B. Rauch ZAR Ludwigshafen Klinikum EuroPRevent 21 Prague some data to the actual situation Depression increases mortality

More information

Depression in Primary Care

Depression in Primary Care Depression in Primary Care Mitchell D. Feldman, MD, MPhil Professor Of Medicine Director of Faculty Mentoring University of California, San Francisco Epidemiology of Depression in Primary Care Prevalence

More information

Effect of Depression on Five-Year Mortality After an Acute Coronary Syndrome

Effect of Depression on Five-Year Mortality After an Acute Coronary Syndrome Effect of Depression on Five-Year Mortality After an Acute Coronary Syndrome Sherry L. Grace, PhD a,b, *, Susan E. Abbey, MD b,c, Moira K. Kapral, MD, MSc b,c,d, Jiming Fang, PhD d, Robert P. Nolan, PhD,

More information

Coronary Heart Disease in Women Go Red for Women

Coronary Heart Disease in Women Go Red for Women Coronary Heart Disease in Women Go Red for Women Dr Fiona Stewart Green Lane Cardiovascular Service and National Women s Health Auckland City Hospital Auckland Heart Group Women are Different from Men

More information

Behavioral Psychology of the Cardiac Patient: Freud Behind the Stethoscope. Disclosures. The Plan. I have no conflicts of interest to disclose.

Behavioral Psychology of the Cardiac Patient: Freud Behind the Stethoscope. Disclosures. The Plan. I have no conflicts of interest to disclose. 12 th Annual Oregon Cardiovascular Symposium June 7, 2015, Portland, Oregon Behavioral Psychology of the Cardiac Patient: Freud Behind the Stethoscope Adrienne H. Kovacs, PhD, CPsych Peter Munk Cardiac

More information

COMPARISON OF THE BECK DEPRESSION INVENTORY-II AND GERIATRIC DEPRESSION SCALE AS SCREENS FOR DEPRESSION IN CARDIAC PATIENTS

COMPARISON OF THE BECK DEPRESSION INVENTORY-II AND GERIATRIC DEPRESSION SCALE AS SCREENS FOR DEPRESSION IN CARDIAC PATIENTS The University of British Columbia COMPARISON OF THE BECK DEPRESSION INVENTORY-II AND GERIATRIC DEPRESSION SCALE AS SCREENS FOR DEPRESSION IN CARDIAC PATIENTS Gail D. Low University of British Columbia

More information

Course of Depressive Symptoms and Medication Adherence After Acute Coronary Syndromes An Electronic Medication Monitoring Study

Course of Depressive Symptoms and Medication Adherence After Acute Coronary Syndromes An Electronic Medication Monitoring Study Journal of the American College of Cardiology Vol. 48, No. 11, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.07.063

More information

Considering depression as a risk marker for incident coronary disease

Considering depression as a risk marker for incident coronary disease Considering depression as a risk marker for incident coronary disease Dr Adrienne O'Neil Senior Research Fellow Melbourne School of Population & Global Health The University of Melbourne & Visiting Fellow

More information

Dyslipidemia in the light of Current Guidelines - Do we change our Practice?

Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dato Dr. David Chew Soon Ping Senior Consultant Cardiologist Institut Jantung Negara Atherosclerotic Cardiovascular Disease

More information

Reviewing the long-term use of selective serotonin reuptake inhibitors in patients with depression

Reviewing the long-term use of selective serotonin reuptake inhibitors in patients with depression CLINICAL AUDIT Reviewing the long-term use of selective serotonin reuptake inhibitors in patients with depression Valid to November 2022 bpac nz better medicin e Audit Focus This audit helps health professionals

More information

Connections Between Depression and Heart Disease

Connections Between Depression and Heart Disease Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/focus-on-heart-health/connections-between-depression-and-heartdisease/4168/

More information

Major depressive disorder (MDD) is present in approximately

Major depressive disorder (MDD) is present in approximately Accuracy and Prognostic Value of American Heart Association Recommended Depression Screening in Patients With Coronary Heart Disease Data From the Heart and Soul Study Larkin Elderon, BA; Kim G. Smolderen,

More information

The TNT Trial Is It Time to Shift Our Goals in Clinical

The TNT Trial Is It Time to Shift Our Goals in Clinical The TNT Trial Is It Time to Shift Our Goals in Clinical Angioplasty Summit Luncheon Symposium Korea Assoc Prof David Colquhoun 29 April 2005 University of Queensland, Wesley Hospital, Brisbane, Australia

More information

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary

More information

Hazard ratio for coronary heart disease mortality for SMI patients versus controls (18-49 yrs) Hazard ratio for stroke

Hazard ratio for coronary heart disease mortality for SMI patients versus controls (18-49 yrs) Hazard ratio for stroke By Michael Dixon Contents Background to Bipolar Disorder and cardiac risk Mood stabilisers and cardiac risk factors Background to Depression and cardiac risk Antidepressants and cardiac risk factors Any

More information

Burden, screening, and treatment of depressive and anxious symptoms among women referred to cardiac rehabilitation: a prospective study

Burden, screening, and treatment of depressive and anxious symptoms among women referred to cardiac rehabilitation: a prospective study Hurley et al. BMC Women's Health (2017) 17:11 DOI 10.1186/s12905-017-0367-1 RESEARCH ARTICLE Open Access Burden, screening, and treatment of depressive and anxious symptoms among women referred to cardiac

More information

Lifetime clinical and economic benefits of statin-based LDL lowering in the 20-year Followup of the West of Scotland Coronary Prevention Study

Lifetime clinical and economic benefits of statin-based LDL lowering in the 20-year Followup of the West of Scotland Coronary Prevention Study Lifetime clinical and economic benefits of statin-based LDL lowering in the 20-year Followup of the West of Scotland Coronary Prevention Study Harvey White Green Lane Cardiovascular Service and Cardiovascular

More information

Nonadherence and Heart Failure

Nonadherence and Heart Failure Adherence and Mental Health Kristin S. Vickers Douglas, Ph.D., ABPP, L.P. Professor of Psychology Mayo Clinic Department of Psychiatry and Psychology 2013 MFMER slide-1 Nonadherence and Heart Failure Poor

More information

Epidemiology and Management of Depression Following Coronary Heart Disease Diagnosis in Women

Epidemiology and Management of Depression Following Coronary Heart Disease Diagnosis in Women City University of New York (CUNY) CUNY Academic Works Publications and Research College of Staten Island Winter 2-23-2012 Epidemiology and Management of Depression Following Coronary Heart Disease Diagnosis

More information

Depression and Cardiovascular Disease

Depression and Cardiovascular Disease Available online at www.sciencedirect.com www.onlinepcd.com Depression and Cardiovascular Disease Larkin Elderon a, Mary A. Whooley b, a UCSF School of Medicine, San Francisco, CA b Departments of Medicine,

More information

Addressing Psychiatric Issues Prior to HCV Treatment. Glenn J. Treisman, MD, PhD The Johns Hopkins University School of Medicine Baltimore, Maryland

Addressing Psychiatric Issues Prior to HCV Treatment. Glenn J. Treisman, MD, PhD The Johns Hopkins University School of Medicine Baltimore, Maryland Addressing Psychiatric Issues Prior to HCV Treatment Glenn J. Treisman, MD, PhD The Johns Hopkins University School of Medicine Baltimore, Maryland Disclosure Information Dr Treisman has not relevant financial

More information

Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A

Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A Faculty/Presenter Disclosures Faculty: Mike Allan Salary: College

More information

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention

More information

10/19/12. Depression in the Medically Ill. Ondria C. Gleason, MD Disclosures. Dr. Gleason has no disclosures to report

10/19/12. Depression in the Medically Ill. Ondria C. Gleason, MD Disclosures. Dr. Gleason has no disclosures to report Depression in the Medically Ill Ondria C. Gleason, MD University of Oklahoma School of Community Medicine Tulsa, OK Ondria C. Gleason, MD Disclosures Dr. Gleason has no disclosures to report 1 Learning

More information

New Paradigms in Predicting CVD Risk

New Paradigms in Predicting CVD Risk New Paradigms in Predicting CVD Risk Imaging as an Integrator of Lifetime Risk Exposure Michael J. Blaha MD MPH Presented by: Michael J. Blaha September 24, 2014 1 Talk Outline Risk factors vs. Disease

More information

Daniel Suzuki, MD Adjunct Clinical Associate Professor of Psychiatry, USC Keck School of Medicine Clinical Adjunct Professor/Faculty, Graduate School

Daniel Suzuki, MD Adjunct Clinical Associate Professor of Psychiatry, USC Keck School of Medicine Clinical Adjunct Professor/Faculty, Graduate School Daniel Suzuki, MD Adjunct Clinical Associate Professor of Psychiatry, USC Keck School of Medicine Clinical Adjunct Professor/Faculty, Graduate School of Psychology, Fuller Theological Seminary Medical

More information

Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A

Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A Faculty/Presenter Disclosures Faculty: Mike Allan Salary: College

More information

Cardiac Patients Psychosocial Needs. Cardiac Patients Psychosocial Needs

Cardiac Patients Psychosocial Needs. Cardiac Patients Psychosocial Needs Cardiac Patients Psychosocial Needs Implications for Rehabilitation Programs and CACR Guidelines Jaan Reitav and Paul Oh Cardiac Rehabilitation & Secondary Prevention Program Cardiac Patients Psychosocial

More information

Depression in Late Life

Depression in Late Life Depression in Late Life Robert Madan MD FRCPC Geriatric Psychiatrist Key Learnings Robert Madan MD FRCPC Key Learnings By the end of the session, participants will be able to List the symptoms of depression

More information

Depression Can it ever be cured?

Depression Can it ever be cured? Depression Can it ever be cured? Disability, Relapses, and the Effect of Treatment Presented by Dr Julian Parmegiani MB BS FRANZCP 1208/370 Pitt St Sydney NSW 2000 12 August 2008 Claims & Underwriting

More information

Summary of guideline for the. treatment of depression RANZCP CLINICAL PRACTICE GUIDELINES ASSESSMENT

Summary of guideline for the. treatment of depression RANZCP CLINICAL PRACTICE GUIDELINES ASSESSMENT RANZCP CLINICAL PRACTICE GUIDELINES Summary of guideline for the RANZCP CLINICAL PRACTICE GUIDELINES treatment of depression Pete M. Ellis, Ian B. Hickie and Don A. R. Smith for the RANZCP Clinical Practice

More information

BACPR -Annual Conference London 2017

BACPR -Annual Conference London 2017 BACPR -Annual Conference London 2017 Psychological Distress in Patients with Cardiac Conditions; Developing Skills in Integrated Care and the Development of the Increasing Access to Psychological Therapies

More information

Treating Depression in Disadvantaged Women: What is the evidence?

Treating Depression in Disadvantaged Women: What is the evidence? Treating Depression in Disadvantaged Women: What is the evidence? Megan Dwight Johnson, MD MPH Associate Professor Medical Director, UWMC Inpatient Psychiatry Department of Psychiatry and Behavioral Sciences

More information

Treating treatment resistant depression

Treating treatment resistant depression Treating treatment resistant depression These slides are the intellectual property of Ian Anderson and must not be reproduced Ian Anderson Neuroscience and Psychiatry Unit University of Manchester and

More information

Post-Stroke Depression (PSD) NIH StrokeNet Grand Rounds, April 26, 2018 Pamela H. Mitchell, PhD, RN, FAAN, FAHA

Post-Stroke Depression (PSD) NIH StrokeNet Grand Rounds, April 26, 2018 Pamela H. Mitchell, PhD, RN, FAAN, FAHA Post-Stroke Depression (PSD) NIH StrokeNet Grand Rounds, April 26, 2018 Pamela H. Mitchell, PhD, RN, FAAN, FAHA Objectives Describe the scope of the problem of depression and stroke Evaluate the evidence

More information

Angelo Compare 1, *, Elena Germani 2, Riccardo Proietti 3 and David Janeway 4

Angelo Compare 1, *, Elena Germani 2, Riccardo Proietti 3 and David Janeway 4 148 Clinical Practice & Epidemiology in Mental Health, 2011, 7, 148-156 Open Access Clinical Psychology and Cardiovascular Disease: An Up-to-Date Clinical Practice Review for Assessment and Treatment of

More information

Medication for Anxiety and Depression. PJ Cowen Department of Psychiatry, University of Oxford

Medication for Anxiety and Depression. PJ Cowen Department of Psychiatry, University of Oxford Medication for Anxiety and Depression PJ Cowen Department of Psychiatry, University of Oxford Topics Medication for anxiety disorders Medication for first line depression treatment Medication for resistant

More information

University of Groningen. Heart in mind mind in heart Tulner, Doriene Marjanka

University of Groningen. Heart in mind mind in heart Tulner, Doriene Marjanka University of Groningen Heart in mind mind in heart Tulner, Doriene Marjanka IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check

More information

Treating Chronic Illness in the PCMH Handout - Depression. A. Guidelines. 1. Control of Symptoms:

Treating Chronic Illness in the PCMH Handout - Depression. A. Guidelines. 1. Control of Symptoms: Treating Chronic Illness in the PCMH Handout - Depression A. Guidelines A quick note on diagnosis: Note: For a major depressive episode a person must have experienced at least five of the nine symptoms

More information

Major Depressive Disorder (MDD) in Children under Age 6

Major Depressive Disorder (MDD) in Children under Age 6 in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 5. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian

More information

Major Depressive Disorder (MDD) in Children under Age 6

Major Depressive Disorder (MDD) in Children under Age 6 in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 6. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian

More information

Depression: selective serotonin reuptake inhibitors

Depression: selective serotonin reuptake inhibitors Depression: selective serotonin reuptake inhibitors Selective serotonin reuptake inhibitors (SSRIs) are considered first-line treatment for the majority of patients with depression. citalopram and fluoxetine

More information

Testing the Asymptomatic CAD Patient: When and Why?

Testing the Asymptomatic CAD Patient: When and Why? Testing the Asymptomatic CAD Patient: When and Why? Timothy M. Bateman M.D. Co-Director, Cardiovascular Radiologic Imaging Mid America Heart Institute Professor of Medicine University of Missouri-Kansas

More information

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected. KEY MESSAGES Major depressive disorder (MDD) is a significant mental health problem that disrupts a person s mood and affects his psychosocial and occupational functioning. It is often under-recognised

More information

Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over)

Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over) Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over) Introduction / Background Treatment comes after diagnosis Diagnosis is based on

More information

Comorbid Conditions and Antipsychotic Use in Patients with Depression

Comorbid Conditions and Antipsychotic Use in Patients with Depression Comorbid Conditions and Antipsychotic Use in Patients with Depression Thomas W. Heinrich, MD Professor of Psychiatry and Family Medicine Director, Division of Consultation-Liaison Psychiatry Medical College

More information

Depression in patients with cardiac disease is highly prevalent

Depression in patients with cardiac disease is highly prevalent Original Article Feasibility and Utility of Screening for Depression and Anxiety Disorders in Patients With Cardiovascular Disease Christopher M. Celano, MD; Laura Suarez, MD; Carol Mastromauro, LICSW;

More information

STROKE PREVENTION 5/11/2015. Stroke Incidence by Age. Cardiogenic Embolism is the most common cause of stroke

STROKE PREVENTION 5/11/2015. Stroke Incidence by Age. Cardiogenic Embolism is the most common cause of stroke (%) (%) 5/11/15 STROKE PREVENTION Stroke Incidence by Age T H E G E N E R A L P R A C T I C E E D U C A T I O N D A Y U N I V E R S I T Y O F Q U E E N S L A N D 3 1 O C T O B E R 2 1 5 A S S O C I A T

More information

Diabetes and Depression

Diabetes and Depression Journal of Stress Physiology & Biochemistry, Vol. 6 No. 3 2010, pp. 38-43 ISSN 1997-0838 Original Text Copyright 2010 by Abass Yavari, Naimeh Mashinchi REVIEW Abass Yavari 1, Naimeh Mashinchi 2 1 Department

More information

ACRA ASM /08/2017

ACRA ASM /08/2017 An avatar-based education application to improve knowledge and response to heart attack symptoms in acute coronary syndrome (ACS) patients: interim analysis from a single-centre, non-blinded, pragmatic

More information

Measurement-based Scales in Major Depressive Disorder:

Measurement-based Scales in Major Depressive Disorder: This program is paid for by Otsuka Pharmaceutical Development & Commercialization, Inc. and Lundbeck, LLC. The speaker is a paid contractor of Otsuka Pharmaceutical Development and Commercialization, Inc.

More information

#CHAIR2016. September 16 17, 2016 The Biltmore Hotel Miami, FL. Sponsored by

#CHAIR2016. September 16 17, 2016 The Biltmore Hotel Miami, FL. Sponsored by #CHAIR2016 September 16 17, 2016 The Biltmore Hotel Miami, FL Sponsored by Depression in Children and Adolescents Karen Dineen Wagner, MD, PhD University of Texas Medical Branch Galveston, TX Karen Dineen

More information

Depression, Anxiety and Cardiovascular disease

Depression, Anxiety and Cardiovascular disease Depression, Anxiety and Cardiovascular disease Kamalika Roy MD Objectives At the end of this activity participants will have a better knowledge of : Prevalence and evaluation of depression and anxiety

More information

The association between type D personality, and depression and anxiety ten years after PCI

The association between type D personality, and depression and anxiety ten years after PCI Neth Heart J (2016) 24:538 543 DOI 10.1007/s12471-016-0860-4 ORIGINAL ARTICLE The association between type D personality, and depression and anxiety ten years after PCI M.N.A. AL-Qezweny 1 E.M.W.J. Utens

More information

INSTRUCTION MANUAL Instructions for Patient Health Questionnaire (PHQ) and GAD-7 Measures

INSTRUCTION MANUAL Instructions for Patient Health Questionnaire (PHQ) and GAD-7 Measures PHQ and GAD-7 Instructions P. 1/9 INSTRUCTION MANUAL Instructions for Patient Health Questionnaire (PHQ) and GAD-7 Measures TOPIC PAGES Background 1 Coding and Scoring 2, 4, 5 Versions 3 Use as Severity

More information

Depressive Symptom Dimensions and Cardiovascular Prognosis among Women with Suspected Myocardial Ischemia

Depressive Symptom Dimensions and Cardiovascular Prognosis among Women with Suspected Myocardial Ischemia Depressive Symptom Dimensions and Cardiovascular Prognosis among Women with Suspected Myocardial Ischemia A Report from the NHLBI- Sponsored Women s Ischemia Syndrome Evaluation (WISE) Society of Behavioral

More information

Recognition and Treatment of Depression and Anxiety in Patients With Acute Myocardial Infarction

Recognition and Treatment of Depression and Anxiety in Patients With Acute Myocardial Infarction Recognition and Treatment of Depression and Anxiety in Patients With Acute Myocardial Infarction Jeff C. Huffman, MD a,c, *, Felicia A. Smith, MD a,c, Mark A. Blais, PsyD a,c, Marguerite E. Beiser, BA

More information

Depression in the Medically Ill

Depression in the Medically Ill Mayo School of Continuous Professional Development Psychiatry in Medical Settings February 9 th, 2017 Depression in the Medically Ill David Katzelnick, M.D. Professor of Psychiatry, Mayo Clinic College

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Weitz ES, Hollon SD, Twisk J, et al. Baseline depression severity as moderator of depression outcomes between cognitive behavioral therapy vs pharmacotherapy: an individual

More information

Post-Stroke Depression Primary Care Stroke Update: What s New in Best Practice Prevention & Care

Post-Stroke Depression Primary Care Stroke Update: What s New in Best Practice Prevention & Care Post-Stroke Depression Primary Care Stroke Update: What s New in Best Practice Prevention & Care Maria Hussain MD FRCPC Dallas Seitz MD PhD(c) FRCPC Division of Geriatric Psychiatry, Queen s University

More information

Cognitive Function and Congenital Heart Disease Anxiety and Depression in Adults with Congenital Heart Disease

Cognitive Function and Congenital Heart Disease Anxiety and Depression in Adults with Congenital Heart Disease Joint Annual Meeting of the Swiss Society of Cardiology and the Swiss Society for Cardio and Thoracic Vascular Surgery Palazzo dei Congressi Lugano: 14 June 2013 Cognitive Function and Congenital Heart

More information

Dr.Rahiminejad Roozbeh Hospital TUMS

Dr.Rahiminejad Roozbeh Hospital TUMS Dr.Rahiminejad Roozbeh Hospital TUMS Psychiatric disorders, particularly depression, anxiety and eating disorders, are prevalent in diabetes. Mental illness increases risk of diabetes and diabetic complications.

More information

Depression among Patients with Coronary Artery Disease in Saudi Arabia

Depression among Patients with Coronary Artery Disease in Saudi Arabia Depression among Patients with Coronary Artery Disease in Saudi Arabia 1 Naeem Alshoaibi, 2 Galya G. Alsharif, 3 Jumanah MS. Ardawi, 4 Lama Andijani, 5 Mohammad Alahdal, 6 Mohamed Nabil, Ama, 7 Imad Hameedullah

More information

Volume 4; Number 5 May 2010

Volume 4; Number 5 May 2010 Volume 4; Number 5 May 2010 CLINICAL GUIDELINES FOR ANTIDEPRESSANT USE IN PRIMARY AND SECONDARY CARE Lincolnshire Partnership Foundation Trust in conjunction with Lincolnshire PACEF have recently updated

More information

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive

More information

Over-diagnosis in pathology testing and the impact on patients

Over-diagnosis in pathology testing and the impact on patients Over-diagnosis in pathology testing and the impact on patients Sally Lord MBBS, MS(Epi) School of Medicine, The University of Notre Dame NHMRC Clinical Trials Centre, The University of Sydney Landmark

More information

Effective Date: 5/28/2014 Version: 2.0 (Revised: 10/12/2015) Approval By: CCC Clinical Delivery Steering Planned Review Date: (04/47/2017)

Effective Date: 5/28/2014 Version: 2.0 (Revised: 10/12/2015) Approval By: CCC Clinical Delivery Steering Planned Review Date: (04/47/2017) Protocol Title: Depression & Generalized Anxiety Disorder Effective Date: 5/28/2014 Version: 2.0 (Revised: 10/12/2015) Approval By: CCC Clinical Delivery Steering Planned Review Date: (04/47/2017) Group

More information

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD Diagnosis & Management of Major Depression: A Review of What s Old and New Cerrone Cohen, MD Why You re Treating So Much Mental Health 59% of Psychiatrists Are Over the Age of 55 AAMC 2014 Physician specialty

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

Considerations in Managing Major Depressive Disorder in Patients With Comorbid Cardiovascular Disease

Considerations in Managing Major Depressive Disorder in Patients With Comorbid Cardiovascular Disease Considerations in Managing Major Depressive Disorder in Patients With Comorbid Cardiovascular Disease Otsuka Pharmaceutical Development & Commercialization, Inc. Lundbeck, LLC 2017 Otsuka Pharmaceutical

More information

HEARTACHE & HEARTBREAK: THE RELATIONSHIP BETWEEN DEPRESSION & HEART DISEASE. Charles B. Nemeroff, MD, PhD University of Miami

HEARTACHE & HEARTBREAK: THE RELATIONSHIP BETWEEN DEPRESSION & HEART DISEASE. Charles B. Nemeroff, MD, PhD University of Miami HEARTACHE & HEARTBREAK: THE RELATIONSHIP BETWEEN DEPRESSION & HEART DISEASE Charles B. Nemeroff, MD, PhD University of Miami CHARLES B. NEMEROFF, MD, PHD Disclosures!! Research/Grants: None!! Speakers

More information

Department of Psychiatry & Behavioral Sciences. University of Texas Medical Branch

Department of Psychiatry & Behavioral Sciences. University of Texas Medical Branch Depression in Childhood: Advances and Controversies in Treatment Karen Dineen Wagner, MD, PhD Marie B. Gale Centennial Professor & Vice Chair Department of Psychiatry & Behavioral Sciences Director, Division

More information

Dyslipidemia: Lots of Good Evidence, Less Good Interpretation.

Dyslipidemia: Lots of Good Evidence, Less Good Interpretation. Dyslipidemia: Lots of Good Evidence, Less Good Interpretation. G Michael Allan Evidence & CPD Program, ACFP Associate Professor, Dept of Family, U of A. CFPC CoI Templates: Slide 1 Faculty/Presenter Disclosure

More information

FOCUS: Fluoxetine Or Control Under Supervision Results. Martin Dennis on behalf of the FOCUS collaborators

FOCUS: Fluoxetine Or Control Under Supervision Results. Martin Dennis on behalf of the FOCUS collaborators FOCUS: Fluoxetine Or Control Under Supervision Results Martin Dennis on behalf of the FOCUS collaborators Background Pre clinical and imaging studies had suggested benefits from fluoxetine (and other SSRIs)

More information

NIH Public Access Author Manuscript Am Heart J. Author manuscript; available in PMC 2013 October 01.

NIH Public Access Author Manuscript Am Heart J. Author manuscript; available in PMC 2013 October 01. NIH Public Access Author Manuscript Published in final edited form as: Am Heart J. 2012 October ; 164(4): 524 529. doi:10.1016/j.ahj.2012.07.024. The Effect of Enhanced Depression Care on Adherence to

More information

Depression After Traumatic Brain Injury (TBI)

Depression After Traumatic Brain Injury (TBI) Depression After Traumatic Brain Injury (TBI) A resource for individuals with traumatic brain injury and their supporters This presentation is based on TBI Model Systems research and was developed with

More information

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment

More information

Pharmaceutical Interventions. Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007

Pharmaceutical Interventions. Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007 Pharmaceutical Interventions Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007 Outline Overview Overview of initial workup and decisions in elderly depressed individual

More information

Psychometric properties of the cardiac depression scale in patients with coronary heart disease

Psychometric properties of the cardiac depression scale in patients with coronary heart disease Kiropoulos et al. BMC Psychiatry 2012, 12:216 RESEARCH ARTICLE Open Access Psychometric properties of the cardiac depression scale in patients with coronary heart disease Litza A Kiropoulos 1,2,3*, Ian

More information

University of Groningen. Somatic depression in the picture Meurs, Maaike

University of Groningen. Somatic depression in the picture Meurs, Maaike University of Groningen Somatic depression in the picture Meurs, Maaike IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the

More information

Primary vs Specialist

Primary vs Specialist Primary vs Specialist Specialist services: Referral-based Preselected Mental health and/or addiction problem salient Primary care: First point of contact Undifferentiated Mental health and/or addiction

More information